Patents by Inventor Marc Isaac Damelin

Marc Isaac Damelin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180296691
    Abstract: The present invention provides for anti-EFNA4 antibody-drug conjugates and methods for preparing and using the same.
    Type: Application
    Filed: January 22, 2018
    Publication date: October 18, 2018
    Applicants: PFIZER, INC., ABBVIE STEMCENTRX LLC
    Inventors: Marc Isaac DAMELIN, Kiran Manohar KHANDKE, Puja SAPRA, Alexander John BANKOVICH, Scott J. DYLLA
  • Publication number: 20180094075
    Abstract: The present invention provides anti-PTK7 antibody-drug conjugates and methods for preparing and using the same.
    Type: Application
    Filed: September 1, 2017
    Publication date: April 5, 2018
    Applicants: PFIZER INC., ABBVIE STEMCENTRX LLC
    Inventors: Marc Isaac DAMELIN, Puja SAPRA, Alexander John BANKOVICH, Scott J. DYLLA
  • Patent number: 9872922
    Abstract: The present invention provides for anti-EFNA4 antibody-drug conjugates and methods for preparing and using the same.
    Type: Grant
    Filed: June 8, 2016
    Date of Patent: January 23, 2018
    Assignees: Pfizer Inc., AbbVie Stemcentrx LLC
    Inventors: Marc Isaac Damelin, Kiran Manohar Khandke, Puja Sapra, Alexander John Bankovich, Scott J. Dylla
  • Patent number: 9777070
    Abstract: The present invention provides anti-PTK7 antibody-drug conjugates and methods for preparing and using the same.
    Type: Grant
    Filed: April 27, 2015
    Date of Patent: October 3, 2017
    Assignees: PFIZER INC, ABBVIE STEMCENTRX LLC
    Inventors: Marc Isaac Damelin, Puja Sapra, Alexander John Bankovich, Scott J. Dylla
  • Publication number: 20170072066
    Abstract: The present invention provides for anti-EFNA4 antibody-drug conjugates and methods for preparing and using the same.
    Type: Application
    Filed: June 8, 2016
    Publication date: March 16, 2017
    Applicants: PFIZER, INC., STEMCENTRX, INC.
    Inventors: Marc Isaac DAMELIN, Kiran Manohar KHANDKE, Puja SAPRA, Alexander John BANKOVICH, Scott J. DYLLA
  • Publication number: 20160326496
    Abstract: Isolated and enriched tumor-initiating cell populations, methods for preparing the same, and uses thereof.
    Type: Application
    Filed: April 14, 2016
    Publication date: November 10, 2016
    Applicant: WYETH LLC
    Inventors: Marc Isaac Damelin, Kenneth G. Geles, Jonathon P. Golas, Erwin Boghaert, Bin-Bing S. Zhou
  • Patent number: 9381205
    Abstract: The present invention provides for anti-EFNA4 antibody-drug conjugates and methods for preparing and using the same.
    Type: Grant
    Filed: October 28, 2014
    Date of Patent: July 5, 2016
    Assignees: Pfizer, Inc., Stemcentrx, Inc.
    Inventors: Marc Isaac Damelin, Kiran Manohar Khandke, Puja Sapra, Alexander John Bankovich, Scott J. Dylla
  • Patent number: 9340774
    Abstract: Isolated and enriched tumor-initiating cell populations, methods for preparing the same, and uses thereof.
    Type: Grant
    Filed: March 26, 2010
    Date of Patent: May 17, 2016
    Assignee: Wyeth LLC
    Inventors: Marc Isaac Damelin, Kenneth G. Geles, Jonathon P. Golas, Erwin Boghaert, Bin-Bing S. Zhou
  • Publication number: 20150315293
    Abstract: The present invention provides anti-PTK7 antibody-drug conjugates and methods for preparing and using the same.
    Type: Application
    Filed: April 27, 2015
    Publication date: November 5, 2015
    Applicants: STEMCENTRX, INC., PFIZER INC.
    Inventors: Marc Isaac DAMELIN, Puja SAPRA, Alexander John BANKOVICH, Scott J. DYLLA
  • Publication number: 20150125472
    Abstract: The present invention provides for anti-EFNA4 antibody-drug conjugates and methods for preparing and using the same.
    Type: Application
    Filed: October 28, 2014
    Publication date: May 7, 2015
    Applicants: STEM CENTRX, INC., PFIZER, INC.
    Inventors: Marc Isaac DAMELIN, Kiran Manohar KHANDKE, Puja SAPRA, Alexander John BANKOVICH, Scott J. DYLLA
  • Publication number: 20120071350
    Abstract: Isolated and enriched tumor-initiating cell populations, methods for preparing the same, and uses thereof.
    Type: Application
    Filed: March 26, 2010
    Publication date: March 22, 2012
    Applicant: WYETH LLC.
    Inventors: Marc Isaac Damelin, Kenneth G, Geles, Jonathon P. Golas, Erwin Boghaert, Bin-Bings S. Zhou